Oruka Therapeutics (ORKA) Analyst & Key Data

Analyst Consensus

Buy18 analysts

Buy

Updated Sep 12, 2026

Total Analysts18

Buy

9

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$92.38

Median Target+15.59%

$106.78

Potential upside vs current price

DCF Value-99.03%

$0.90

Potential downside vs current price

Current Stock Price

$92.38

Median Target+15.59%

$106.78

Potential upside vs current price

DCF Value-99.03%

$0.90

Potential downside vs current price

Analyst Consensus

Buy18 analysts

Buy

Updated Sep 12, 2026

Total Analysts18

Buy

9

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$92.38

Median Target+15.59%

$106.78

Potential upside vs current price

DCF Value-99.03%

$0.90

Potential downside vs current price

Current Stock Price

$92.38

Median Target+15.59%

$106.78

Potential upside vs current price

DCF Value-99.03%

$0.90

Potential downside vs current price

Oruka Therapeutics, Inc.